Clinical Trial

Lifestyle, Fitness, and Plasma Biomarkers in Healthy Young Adults

Study acronym: NEUROACTIVE
Completed
View on ClinicalTrials.gov →
Summary
Lifestyle play a key role in modulating brain health by directly influencing a number of key biological processes, such as neuroplasticity, neurogenesis, and regulation of biomarkers associated with cognitive decline. Factors such as physical activity, diet, sleep quality, stress management, and body composition have been shown to have a significant impact on neuroprotection and cognitive performance. These factors not only contribute to maintaining metabolic and functional balance in the body, but are also linked to the expression of biomarkers such as brain-derived neurotrophic factor (BDNF) and Tau protein phosphorylated at the amino acid threonine 217 (PTau217), which are essential for the maintenance of neuronal health and the prevention of neurodegenerative diseases. In this sense, a healthy lifestyle, characterized by regular physical activity, a balanced diet, good quality sleep, low stress levels and adequate body composition, can act as a protective factor against cognitive decline from early stages of life.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-13; most recent amendment 2026-03-06.
Status change: Recruiting → Completed 2026-03-06
Trial Details
NCT Number NCT07032168
Lead Sponsor European University Miguel de Cervantes
Conditions Healthy Young Adults
Enrollment 31 participants
Start Date 2025-06-16
Primary Completion 2025-10-31 (estimated)
Study Completion 2025-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-09